Merck, Kelun ink billion dollar biobucks deal – FierceBiotech
Merck, Kelun ink billion dollar biobucks deal FierceBiotech Source link
Merck, Kelun ink billion dollar biobucks deal FierceBiotech Source link
Novo Nordisk, Flagship's forward-thinking partnership aims to treat cardiometabolic, rare diseases FierceBiotech Source link
Orion aims to challenge Vertex with new pain management licensing deal FierceBiotech Source link
Moderna's CEO, busy amid M&A talks FierceBiotech Source link
Anti-aging for the liver? Researchers find way to de-age liver cells FierceBiotech Source link
Solid Biosciences lays off 35% of workforce, chief operating officer exits FierceBiotech Source link
BridgeBio strategy head departs amid company's 2nd round of layoffs this year FierceBiotech Source link
Cytovia inks SPAC merger to get natural killer cells prospects into the clinic FierceBiotech Source link
Windtree's cardiogenic shock medicine istaroxime met its phase 2 trial endpoint FierceBiotech Source link
Bristol Myers Squibb Foundation unites with Gilead to boost diversity among clinical trial investigators FierceBiotech Source link
M | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | 2 | 3 | ||||
4 | 5 | 6 | 7 | 8 | 9 | 10 |
11 | 12 | 13 | 14 | 15 | 16 | 17 |
18 | 19 | 20 | 21 | 22 | 23 | 24 |
25 | 26 | 27 | 28 | 29 | 30 |
© 2021 Nutrition Center.
© 2021 Nutrition Center.